Effect of antidepressive therapy on retinal contrast processing in depressive disorder

British Journal of Psychiatry

Volumn 201, Issue 2, 2012, Pages 151-158

  Bubl, Emanuel ^a   Ebert, Dieter ^a   Kern, Elena ^a   Van Elst, Ludger Tebartz ^a   Bach, Michael ^b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE; BIOLOGICAL MARKER; LITHIUM; MIRTAZAPINE; QUETIAPINE; RETINAL CONTRAST GAIN; RISPERIDONE; TRICYCLIC ANTIDEPRESSANT AGENT; UNCLASSIFIED DRUG; VENLAFAXINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ELECTRORETINOGRAM; FEMALE; FOLLOW UP; HUMAN; MAJOR DEPRESSION; MALE; REMISSION;

ADULT; ANTIDEPRESSIVE AGENTS; CASE-CONTROL STUDIES; CONTRAST SENSITIVITY; DEPRESSIVE DISORDER, MAJOR; ELECTRORETINOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; TIME FACTORS; VISION DISORDERS;

EID: 84864551862     PISSN: 00071250     EISSN: 14721465     Source Type: Journal    
DOI: 10.1192/bjp.bp.111.100560     Document Type: Article

References (43)

1. Gong Q, Wu Q, Scarpazza C, Lui S, Jia Z, Marquand A, Huang X, et al. Prognostic prediction of therapeutic response in depression using high-field MR imaging. Neuroimage 2011; 55: 1497-503.
2. Chen Y, Wan HI, O'Reardon JP, Wang DJJ, Wang Z, Korczykowski M, et al. Quantification of cerebral blood flow as biomarker of drug effect: arterial spin labeling phMRI after a single dose of oral citalopram. Clin Pharmacol Ther 2011; 89: 251-8.
3. Domenici E, Willé DR, Tozzi F, Prokopenko I, Miller S, McKeown A, et al. Plasma protein biomarkers for depression and schizophrenia by multi analyte profiling of case-control collections. PLoS One 2010; 5: e9166.
4. Farb NAS, Anderson AK, Bloch RT, Segal ZV. Mood-linked responses in medial prefrontal cortex predict relapse in patients with recurrent unipolar depression. Biol Psychiatry 2011; 70: 366-72.
5. Landsness EC, Goldstein MR, Peterson MJ, Tononi G, Benca RM. Antidepressant effects of selective slow wave sleep deprivation in major depression: a high-density EEG investigation. J Psychiatr Res 2011; 45: 1019-26.
6. Bubl E, Tebartz van Elst L, Gondan M, Ebert D, Greenlee MW. Vision in depressive disorder. World J Biol Psychiatry 2009; 10: 377-84.
7. Normann C, Schmitz D, Fürmaier A, Döing C, Bach M. Long-term plasticity of visually evoked potentials in humans is altered in major depression. Biol Psychiatry 2007; 62: 373-80. (Pubitemid 47284020)
8. Lavoie M-P, Lam RW, Bouchard G, Sasseville A, Charron M-C, Gagné A-M, et al. Evidence of a biological effect of light therapy on the retina of patients with seasonal affective disorder. Biol Psychiatry 2009; 66: 253-8.
9. Joost W, Bach M, Schulte-Mönting J. Influence of mood on visually evoked potentials: a prospective longitudinal study. Int J Psychophysiol 1992; 12: 147-53.
10. Maffei L, Fiorentini A. Electroretinographic responses to alternating gratings before and after section of the optic nerve. Science 1981; 211: 953-5. (Pubitemid 11141462)
11. Bach M, Hoffman M. The origin of the pattern electroretinogram (PERG). In Principles and Practice of Clinical Electrophysiology of Vision (eds J Heckenlively, G Arden): 185-96. MIT Press, 2006.
12. Tebartz van Elst L, Greenlee MW, Foley JM, Lucking CH. Contrast detection, discrimination and adaptation in patients with Parkinson's disease and multiple system atrophy. Brain 1997; 120 (Pt 12): 2219-28. (Pubitemid 28014598)
13. Ghilardi MF, Marx MS, Bodis-Wollner I, Camras CB, Glover AA. The effect of intraocular 6-hydroxydopamine on retinal processing of primates. Ann Neurol 1989; 25: 357-64. (Pubitemid 19104167)
14. Hasler G, Fromm S, Carlson PJ, Luckenbaugh DA, Waldeck T, Geraci M, et al. Neural response to catecholamine depletion in unmedicated subjects with major depressive disorder in remission and healthy subjects. Arch Gen Psychiatry 2008; 65: 521-31. (Pubitemid 351645048)
15. Ben-Shlomo G, Bach M, Ofri R. Temporal and spatial frequencies interact in the contrast transfer function of the pattern electroretinogram. Vision Res 2007; 47: 1992-9. (Pubitemid 46907253)
16. Bubl E, Kern E, Ebert D, Bach M, Tebartz van Elst L. Seeing gray when feeling blue? Depression can be measured in the eye of the diseased. Biol Psychiatry 2010; 68: 205-8.
17. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (4th edn) (DSM-IV). APA, 1994.
18. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J ClinPsychiatry 1998; 59 (suppl 20): 22-33. (Pubitemid 29001829)
19. Hautzinger M, Bailer M, Worrall H, Keller F. Das Beck-Depressions- Inventar (BDI). Überarbeitet und ergänzte Neuauflage. Hans Huber, 1995.
20. Collegium Internationale Psychiatriae Scalarum. Internationale Skalen für Psychiatrie. Beltz Test, 1977.
21. Keller MB. Undertreatment of major depression. Psychopharmacol Bull 1988; 24: 75-80.
22. Leon AC, Solomon DA, Mueller TI, Endicott J, Rice JP, Maser JD, et al. A 20-year longitudinal observational study of somatic antidepressant treatment effectiveness. Am J Psychiatry 2003; 160: 727-33. (Pubitemid 41079606)
23. Bach M. The Freiburg Visual Acuity Test - variability unchanged by post-hoc re-analysis. Graefes Arch Clin Exp Ophthalmol 2007; 245: 965-71. (Pubitemid 46979536)
24. Bach M. Freiburg Evoked Potentials. Bach, 2000 (http://www.michaelbach. de/ep2000/index.html).
25. Bach M. Preparation and Montage of DTL-Electrodes. University of Freiburg, 2007. (http://www.uniklinik-freiburg.de/augenklinik/live/homede/mit/ bach/ops/dtl-en.html).
26. Otto T, Bach M. Retest variability and diurnal effects in the pattern electroretinogram. Doc Ophthalmol 1996; 92: 311-23.
27. Bach M, Meigen T. Do's and don'ts in Fourier analysis of steady-state potentials. Doc Ophthalmol 1999; 99: 69-82. (Pubitemid 30495271)
28. Meigen T, Bach M. On the statistical significance of electrophysiological steady-state responses. Doc Ophthalmol 1999; 98: 207-32. (Pubitemid 30458369)
29. R Development Core Team. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, 2010.
30. Bodis-Wollner I, Yahr MD. Measurements of visual evoked potentials in Parkinson's disease. Brain 1978; 101: 661-71. (Pubitemid 9051163)
31. Bodis-Wollner I, Marx MS, Mitra S, Bobak P, Mylin L, Yahr M. Visual dysfunction in Parkinson's disease. Loss in spatiotemporal contrast sensitivity. Brain 1987; 110: 1675-98.
32. Glover A, Ghilardi MF, Bodis-Wollner I, Onofrj M. Alterations in event-related potentials (ERPs) of MPTP-treated monkeys. Electroencephalogr Clin Neurophysiol 1988; 71: 461-8.
33. Langheinrich T, Tebartz van Elst, Lagrèze WA, Bach M, Lücking CH, Greenlee MW. Visual contrast response functions in Parkinson's disease: evidence from electroretinograms, visually evoked potentials and psychophysics. Clin Neurophysiol 2000; 111: 66-74.
34. Iuvone PM, Galli CL, Garrison-Gund CK, Neff NH. Light stimulates tyrosine hydroxylase activity and dopamine synthesis in retinal amacrine neurons. Science 1978; 202: 901-2. (Pubitemid 9077590)
35. Djamgoz MB, Hankins MW, Hirano J, Archer SN. Neurobiology of retinal dopamine in relation to degenerative states of the tissue. Vision Res 1997; 37: 3509-29. (Pubitemid 27491631)
36. Ebert D, Feistel H, Kaschka W, Barocka A, Pirner A. Single photon emission computerized tomography assessment of cerebral dopamine D2 receptor blockade in depression before and after sleep deprivation-preliminary results. Biol Psychiatry 1994; 35: 880-5. (Pubitemid 24165013)
37. Hamilton JP, Chen G, Thomason ME, Schwartz ME, Gotlib IH. Investigating neural primacy in major depressive disorder: multivariate Granger causality analysis of resting-state fMRI time-series data. Mol Psychiatry 2011; 16: 763-72.
38. Saijo T, Takano A, Suhara T, Arakawa R, Okumura M, Ichimiya T, et al. Electroconvulsive therapy decreases dopamine D2 receptor binding in the anterior cingulate in patients with depression: a controlled study using positron emission tomography with radioligand [11C]FLB 457. J Clin Psychiatry 2010; 71: 793-9.
39. Pei L, Li S, Wang M, Diwan M, Anisman H, Fletcher PJ, et al. Uncoupling the dopamine D1-D2 receptor complex exerts antidepressant-like effects. Nat Med 2010; 16: 1393-5.
40. Schilström B, Konradsson-Geuken A, Ivanov V, Gertow J, Feltmann K, Marcus MM, et al. Effects of S-citalopram, citalopram, and R-citalopram on the firing patterns of dopamine neurons in the ventral tegmental area, N-methyl-D-aspartate receptor-mediated transmission in the medial prefrontal cortex and cognitive function in the rat. Synapse 2011; 65: 357-67.
41. Seggie J, Canny C, Mai F, McCrank E, Waring E. Antidepressant medication reverses increased sensitivity to light in depression: preliminary report. Prog Neuropsychopharmacol Biol Psychiatry 1989; 13: 537-41. (Pubitemid 19163804)
42. Volkow ND, Wang G-J, Telang F, Fowler JS, Logan J, Wong C, et al. Sleep deprivation decreases binding of [11C]raclopride to dopamine D2/D3 receptors in the human brain. J Neurosci 2008; 28: 8454-61.
43. Friedman J, Meares R. The effect of placebo and tricyclic antidepressants on cortical evoked potentials in depressed patients. Biol Psychol 1979; 8: 291-302. (Pubitemid 10231938)